EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Landscape of Lyme Borreliosis Surveillance in Europe

Archana Nagarajan, Jozica Skufca, Andrew Vyse, Andreas Pilz, Elizabeth Begier, Margarita Riera-Montes, Bradford D Gessner, James H Stark iD

Vector-Borne and Zoonotic Diseases · 2023

DOI: 10.1089/vbz.2022.0067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vector-Borne and Zoonotic Diseases, 2023. Verfasst von Archana Nagarajan und 7 weiteren Autor:innen. Beteiligte Einrichtung: P95 Epidemiology & Pharmacovigilance, Leuven, Belgium. Hauptthemen laut MEDLINE: Lyme Disease, Tick-Borne Diseases. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Lyme borreliosis (LB) is the most prevalent tick-borne disease in Europe and the incidence of LB is increasing owing to an expansion in tick habitats. However, LB surveillance is quite heterogeneous across the continent, and for those countries with publicly available data, it is difficult to understand the differences in incidence between countries. The objective of our study was to summarize the publicly available data from surveillance for LB in the form of surveillance reports and/or dashboards and to compare the information available for various countries.

Methods

We identified publicly available LB data (online dashboards and surveillance reports) in the European Union, European Economic Area, the United Kingdom, Russia, and Switzerland.

Results

Of the 36 countries studied, 28 had LB surveillance in place; 23 had surveillance reports, and 10 had dashboards. The dashboards, in general, had more granular data compared with the surveillance reports, but the reports covered longer time periods. LB annual cases, incidence, age, and sex-stratified LB data; manifestations; and regional data were available for most of the countries. LB case definitions varied significantly among the countries.

Conclusion

The study highlights large differences in LB surveillance systems, including representativeness, case definitions, type of data available that might inhibit comparison of data between countries and accurate determination of burden of disease, and risk groups within countries. Standardization of case definitions across countries would be a useful first step enabling comparisons between countries and contribute to recognizing the true burden of LB in Europe.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lyme DiseaseTick-Borne DiseasesAnimalsEuropeRisk FactorsUnited KingdomIncidence

Stichwörter der Autor:innen

EuropeLyme borreliosisdashboardssurveillancevaccine

Autor:innen und Institutionen

  • P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
  • Vaccines Medical Affairs, Pfizer UK Ltd, Tadworth, United Kingdom.
  • Pfizer Global Medical Affairs, Vaccines, Vienna, Austria.
  • Vaccine Clinical Research and Development, Pfizer Inc, Pearl River, New York, USA.
  • Vaccines Medical Development, Scientific and Clinical Affairs, Pfizer Inc, Collegeville, Pennsylvania, USA.

ORCID-Profile: James H Stark

Zitieren

APA

Nagarajan, A., Skufca, J., Vyse, A., Pilz, A., Begier, E., Riera-Montes, M., Gessner, B. D., & Stark, J. H. (2023). The Landscape of Lyme Borreliosis Surveillance in Europe. Vector-Borne and Zoonotic Diseases. https://doi.org/10.1089/vbz.2022.0067

Vancouver

Nagarajan A, Skufca J, Vyse A, Pilz A, Begier E, Riera-Montes M, et al. The Landscape of Lyme Borreliosis Surveillance in Europe. Vector-Borne and Zoonotic Diseases. 2023. doi:10.1089/vbz.2022.0067

BibTeX
@article{Nagarajan2023,
  author = {Nagarajan, Archana and Skufca, Jozica and Vyse, Andrew and Pilz, Andreas and Begier, Elizabeth and Riera-Montes, Margarita and Gessner, Bradford D and Stark, James H},
  title = {The Landscape of Lyme Borreliosis Surveillance in Europe},
  journal = {Vector-Borne and Zoonotic Diseases},
  year = {2023},
  doi = {10.1089/vbz.2022.0067}
}
Kostenlos starten →